![Kate Hermans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kate Hermans
Director/Board Member at AMBRX INC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Daniel O'Connor | M | 59 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
Paul Maier | M | 76 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
Janet Loesberg | M | 61 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
Sonja Nelson | F | 51 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 3 years |
Margaret Dalesandro | M | 77 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
Jared Kelly | M | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
Stephen Glover | M | 60 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
Xiaowei Chang | M | 41 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 9 years |
Ying Buechler | M | - | 6 years | |
Shawn Zhang | M | - | - | |
Andrew Aromando | M | 55 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
Glen Gaddy | M | - |
Mid-Atlantic Diamond Ventures
![]() Mid-Atlantic Diamond Ventures Investment ManagersFinance Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA. | - |
Renu Vaish | F | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
Ellen Edelman Weber | F | - |
Mid-Atlantic Diamond Ventures
![]() Mid-Atlantic Diamond Ventures Investment ManagersFinance Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA. | - |
Janice Lu | M | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
Cheryl Brubaker | F | - |
Women's Resource Center
| - |
Bill Mikus | M | - |
Alzheimer's Association Delaware Valley Chapter
![]() Alzheimer's Association Delaware Valley Chapter Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association Delaware Valley Chapter provides information and resources for Alzheimer's and other dementias. The non-profit company is based in Philadelphia, PA. The organization is a part of the Alzheimer's Association national site, which offers information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care, and support resources. | - |
Jordan Warshafsky | M | - |
Mid-Atlantic Diamond Ventures
![]() Mid-Atlantic Diamond Ventures Investment ManagersFinance Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA. | - |
Sandra Aung | M | - | 1 years | |
Carlton Rose | M | 62 |
Women's Resource Center
| - |
Jessica Walsh | F | - |
Women's Resource Center
| 4 years |
Deirdre Powell White | F | - |
Women's Resource Center
| - |
Karen Toren | F | - |
Women's Resource Center
| 11 years |
Jessica Dahill | F | - |
Women's Resource Center
| - |
Eleni Tavantzis | F | - |
Women's Resource Center
| - |
Kathleen M. Yanoshak | F | - |
Women's Resource Center
| - |
Joslyn Ewart | M | - |
Women's Resource Center
| - |
Martha J. Bedeian | F | - |
Women's Resource Center
| - |
Jakob Dupont | M | 58 | 3 years | |
Bernard Rudnick | M | - |
Mid-Atlantic Diamond Ventures
![]() Mid-Atlantic Diamond Ventures Investment ManagersFinance Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA. | - |
Jill Hamilton | F | - |
Women's Resource Center
| - |
Paul D. Bach | M | 64 |
Alzheimer's Association Delaware Valley Chapter
![]() Alzheimer's Association Delaware Valley Chapter Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association Delaware Valley Chapter provides information and resources for Alzheimer's and other dementias. The non-profit company is based in Philadelphia, PA. The organization is a part of the Alzheimer's Association national site, which offers information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care, and support resources. | - |
P. Michael Walker | M | - |
Alzheimer's Association Delaware Valley Chapter
![]() Alzheimer's Association Delaware Valley Chapter Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association Delaware Valley Chapter provides information and resources for Alzheimer's and other dementias. The non-profit company is based in Philadelphia, PA. The organization is a part of the Alzheimer's Association national site, which offers information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care, and support resources. | - |
Carol Lynn Jane | F | - |
Women's Resource Center
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Feng Tian | M | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 18 years |
Robert E. Ward | M | 66 | 4 years | |
Brian Harvey | M | 63 | 11 years | |
Katrin Rupalla | M | 56 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
Jesper Høiland | M | 63 | 3 years | |
Jose Carmona | M | 51 | 3 years | |
Ansbert Gadicke | M | 66 | 6 years | |
Alan Auerbach | M | 54 | 6 years | |
Elhan Webb | F | - | - | |
Edward Hu | M | 61 |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
Dinesh Purandare | M | 60 | 2 years | |
David P. Snow | M | 62 | 2 years | |
Alice Lin Pomponio | F | - | 2 years | |
Joseph Kelly | M | 55 | 3 years | |
Amanda Mott | F | - | - | |
Deepa Desai | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 43 | 86.00% |
Cayman Islands | 14 | 28.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kate Hermans
- Personal Network